This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Venetoclax for patients with chronic lymphocytic l...
Journal

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.

Read time: 1 mins
Published:12th Apr 2018
Author: Coutre S, Choi M, Furman RR, Eradat H, Heffner L, Jones JA et al.
Source: Blood
Availability: Free full text
Ref.:Blood. 2018;131(15):1704-1711.
DOI:10.1182/blood-2017-06-788133
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest